Page 158 - 2022 Ranger Medic Handbook
P. 158

ATROPINE SULFATE
         Class: CNS agent – anticholinergic parasympatholytic, antidysrhythmic, antimuscarinic belladonna alkaloid
         Action: Blocks acetylcholine at parasympathetic neuroeffector sites; increases cardiac output and heart rate by block-
         ing vagal stimulation in heart; dries secretions by blocking vagus
         Dose: Organophosphate poisoning (CBRN nerve agent):1–6mg IV/IM q3–5min PRN × 2–12hr. Bradycardia: 0.5mg
         IV/IM q3–5min (max 3mg)
         Indications: Bradycardia, organophosphate poisoning, reversal of anticholinesterase agents, and decreasing secre-
         tions before surgery
         Contraindications: Hypersensitivity to belladonna alkaloids, glaucoma, GI obstructions, ulcerative colitis, tachycar-
         dia/tachydysrhythmias, asthma, acute hemorrhage, myocardial ischemia, pregnancy category caution advised during
         pregnancy and while breastfeeding
         Adverse/Side-effects: Headache, dizziness, involuntary movements, confusion, psychosis, anxiety, drowsiness, in-
         somnia, hypotension, blurred vision, photophobia, pupil dilation, dry mouth, nausea, vomiting, constipation, abdomi-
         nal distention, rash, urticaria, dry skin, urine retention.
    SECTION 4  Interactions: increase anticholinergic effects of tricyclics, decreased absorption with ketoconazole, decreased effect
         of atropine with antacids

         AZITHROMYCIN (ZITHROMYCIN, Z-Pak)
         Class: Antimicrobial – antibiotic; macrolide
         Action: Reversibly binds to 50S ribosomal subunit of susceptible organisms inhibiting protein synthesis; effective
         against mild to moderate infections caused by pyogenic streptococci, Streptococcus pneumoniae, Haemophilus in-
         fluenzae, Mycobacterium avium intracellulare, and Staphylococcus aureus
         Dose: Pneumonia: 500mg PO on day 1, then 250mg qd × 4 days; 500mg PO qd × 3 days; or suspension 2g single
         dose. STI (gonococcal): 1g PO × 1 in adjunction with ceftriaxone.
         Indications: For pneumonia, lower respiratory tract infections, pharyngitis, tonsillitis, gonorrhea, nongonococcal urethri-
         tis, skin infections, otitis media, and acute bacterial sinusitis
         Contraindications: Macrolide hypersensitivity; pregnancy category may use during pregnancy and while breastfeeding
         Adverse/Side-effects: Headache, dizziness; nausea, vomiting, diarrhea, abdominal pain; hepatotoxicity
         Interactions: Antacids may decrease peak level; may increase toxicity of ergotamine; food will decrease the amount
         of azithromycin absorbed by 50%
         Mission Impact: GROUNDING medication for personnel on flight status

         BACITRACIN
         Class: Antimicrobial – antibiotic
         Action: Polypeptide derived from Bacillus subtilis culture; bactericidal/bacteriostatic that appears to inhibit cell wall
         synthesis; activity similar to penicillin; active against many gram-positives including Streptococcus, Staphylococcus,
         Pneumococcus, Corynebacteria, Clostridia, Neisseria, Gonococcus, Meningococcus, Haemophilus influenzae, and
         Treponema pallidum; ineffective against most other gram-negatives
         Dose: Topical ointment to AAA bid–tid, clean affected area prior to application
         Indications: For topical treatment of superficial skin infections
         Contraindications: Atopic individuals; pregnancy category may use during pregnancy and while breastfeeding
         Adverse/Side-effects: Bacitracin hypersensitivity (erythema, anaphylaxis)
         Interactions: No clinically significant interactions established when given topically

        144      SECTION 4   RANGER MEDIC PHARMACOLOGY & FORMULARY
   153   154   155   156   157   158   159   160   161   162   163